BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33300981)

  • 1. Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.
    Moosavi M; Wooten M; Goodman A; Nahab FB; Duncan A; Maier C; Guarner J
    Am J Clin Pathol; 2021 Mar; 155(4):498-505. PubMed ID: 33300981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).
    Al-Samkari H; Song F; Van Cott EM; Kuter DJ; Rosovsky R
    Am J Hematol; 2020 Dec; 95(12):1479-1485. PubMed ID: 32780525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease.
    Miller MJ; Maier CL; Duncan A; Guarner J
    Clin Appl Thromb Hemost; 2021; 27():10760296211032292. PubMed ID: 34235983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
    Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
    J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia and enhancement of coagulation are associated with severe COVID-19 infection.
    Helin TA; Lemponen M; Lahtiharju T; Koskinen M; Lassila R; Joutsi-Korhonen L
    Scand J Clin Lab Invest; 2021 Dec; 81(8):653-660. PubMed ID: 34793272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an admission coagulation panel for risk stratification of COVID-19 patients.
    Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL; Guarner J; Duncan A; Nahab F
    PLoS One; 2021; 16(3):e0248230. PubMed ID: 33740793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
    Hong LZ; Shou ZX; Zheng DM; Jin X
    Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulopathy in COVID-19.
    Iba T; Levy JH; Levi M; Thachil J
    J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19.
    Elieh Ali Komi D; Rahimi Y; Asghari R; Jafari R; Rasouli J; Mohebalizadeh M; Abbasi A; Nejadrahim R; Rezazadeh F; Shafiei-Irannejad V
    Front Immunol; 2021; 12():762782. PubMed ID: 34975853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
    Görlinger K; Dirkmann D; Gandhi A; Simioni P
    Anesth Analg; 2020 Nov; 131(5):1324-1333. PubMed ID: 33079850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study.
    Zhang W; Sang L; Shi J; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Zhang D; Yu Y; Zheng X
    Aging (Albany NY); 2021 Feb; 13(4):4794-4810. PubMed ID: 33591951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus-induced coagulopathy during the course of disease.
    Friedrich MS; Studt JD; Braun J; Spahn DR; Kaserer A
    PLoS One; 2020; 15(12):e0243409. PubMed ID: 33332362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
    Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L
    J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.